AR045241A1 - TOPICAL COMPOSITION INCLUDING TERBINAFINE AND HYDROCORTISONE - Google Patents

TOPICAL COMPOSITION INCLUDING TERBINAFINE AND HYDROCORTISONE

Info

Publication number
AR045241A1
AR045241A1 ARP040102858A ARP040102858A AR045241A1 AR 045241 A1 AR045241 A1 AR 045241A1 AR P040102858 A ARP040102858 A AR P040102858A AR P040102858 A ARP040102858 A AR P040102858A AR 045241 A1 AR045241 A1 AR 045241A1
Authority
AR
Argentina
Prior art keywords
hydrocortisone
composition including
topical composition
terbinafine
including terbinafine
Prior art date
Application number
ARP040102858A
Other languages
Spanish (es)
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34717190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR045241(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of AR045241A1 publication Critical patent/AR045241A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones farmacéuticas tópicas que comprenden terbinafina e hidrocortisona. Dichas composiciones exhiben propiedades antimicóticas, especialmente contra dermatófitos.Topical pharmaceutical compositions comprising terbinafine and hydrocortisone. Such compositions exhibit antifungal properties, especially against dermatophytes.

ARP040102858A 2003-08-12 2004-08-10 TOPICAL COMPOSITION INCLUDING TERBINAFINE AND HYDROCORTISONE AR045241A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03018271 2003-08-12

Publications (1)

Publication Number Publication Date
AR045241A1 true AR045241A1 (en) 2005-10-19

Family

ID=34717190

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102858A AR045241A1 (en) 2003-08-12 2004-08-10 TOPICAL COMPOSITION INCLUDING TERBINAFINE AND HYDROCORTISONE

Country Status (8)

Country Link
EP (1) EP1656125A2 (en)
JP (1) JP2007501832A (en)
AR (1) AR045241A1 (en)
AU (1) AU2004262934B2 (en)
CA (1) CA2535235A1 (en)
PE (1) PE20050359A1 (en)
TW (1) TW200511987A (en)
WO (1) WO2005013955A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
KR101333892B1 (en) * 2005-09-29 2013-11-27 노파르티스 아게 Antifungal composition
CN101262848B (en) * 2005-09-29 2011-05-11 诺瓦提斯公司 Antifungal composition
MXPA05012961A (en) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Nail care preparations containing terbinafine hydrochloride.
WO2008026381A1 (en) 2006-08-28 2008-03-06 Hisamitsu Pharmaceutical Co., Inc. Nail patch
CN101677953A (en) * 2007-02-21 2010-03-24 纸型电池有限公司 Terbinafine formulation for iontophoresis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287653B6 (en) * 1999-04-23 2011-05-06 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Non-aqueous pharmaceutical composition for dermal use

Also Published As

Publication number Publication date
CA2535235A1 (en) 2005-02-17
WO2005013955A2 (en) 2005-02-17
EP1656125A2 (en) 2006-05-17
AU2004262934A1 (en) 2005-02-17
TW200511987A (en) 2005-04-01
WO2005013955A3 (en) 2005-04-28
PE20050359A1 (en) 2005-06-27
AU2004262934B2 (en) 2007-11-29
WO2005013955A8 (en) 2005-07-14
JP2007501832A (en) 2007-02-01

Similar Documents

Publication Publication Date Title
AR033023A1 (en) TOPICAL COMPOSITION
AR048878A1 (en) TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE
ATE534383T1 (en) COMPOSITIONS OF N-Ä2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYLÜ-1,4-DIHYDRO-4-OXOCINOLIN-3-CARBOXAMIDE
TW200738817A (en) Blends of biopolymers with acrylic copolymers
BRPI0518334A2 (en) coating composition, coating method, coating, and method for preparing a coating composition
MXPA05007328A (en) Compositions containing anti-acne agents and the use thereof.
MX2009013317A (en) Prolonged effect disinfectant cleanser.
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
MX2009009463A (en) Fast-dissolving/disintegrating film preparation having high proportion of active.
TW200738283A (en) Formulations of conjugated estrogens and bazedoxifene
DE602007012551D1 (en) HAIR CONDITIONING COMPOSITIONS AGAINST SCHUPPEN
MY142044A (en) Endoparasiticidal compositions for topical application
AR059445A1 (en) COMPOSITIONS OF RAMNOLIPIDIC ANTIMICOTICS AND RELATED METHODS OF USE
ECSP044981A (en) OPHTHALMIC COMPOSITION THAT INCLUDES ASCOMYCIN
MX2010005589A (en) Personal care composition.
TW200719881A (en) Sedative effect-enabling agent and sedative aroma composition comprising the same
PL1843778T3 (en) Compositions comprising epigallocatechin gallate and protein hydrolysate
NO20073762L (en) Visco-supplement composition and methods
AR058141A1 (en) TOPIC COMPOSITIONS OF N, 2,3 -TRIMETHYL-2- ISOPROPILBUTAMIDE FOR PAIN RELIEF AND METHODS FOR USE
WO2008110995A3 (en) Solubilizing system for volatile ingredients
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
MX2009012370A (en) Low-viscous anthracycline formulation.
AR045241A1 (en) TOPICAL COMPOSITION INCLUDING TERBINAFINE AND HYDROCORTISONE
RS51534B (en) NEW ASSOCIATION OF AN If SINUSOIDAL CURRENT INHIBITOR AND A CALCIUM CHANNEL-BLOCKING AGENT, AND PHARMACEUTICAL INGREDIENTS CONTAINING SAID ASSOCIATION
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal